Pharmaceuticals, Biotechnology and Life Sciences
Lille (France), Cambridge (Massachusetts, United States), September 29, 2022 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated…
SAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) — Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing…
Data from a First-in-Human feasibility trial to treat glaucoma demonstrated a 45% drop in mean intraocular pressure at 3 months.…
– Data demonstrated [18F]OP-801 is a promising tracer for imaging activated macrophages/microglia with high sensitivity in the lumbar spine of…
Successfully met the primary and all secondary endpoints On track for New Drug Application (NDA) filing, with the FDA in…
Please follow this link for images SALINAS, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) — Lowell Farms Inc. (the “Company”) (CSE:…
COMBINEDBrain takes steps to break down language barriers perpetuating health inequity in research by translating patient registry informed consent and…
FIRDAPSE is Now a Treatment Option for All LEMS Patients 6 Years of Age and Older in the U.S.CORAL GABLES,…
WOBURN, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of…
LAVAL, Québec, Sept. 29, 2022 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST and TSX-V: ACST),…